Oct 22, 2026 08:30AM
Oct 15, 2026 08:04AM
Oct 15, 2026 08:00AM
Oct 9, 2026 08:00AM
Sep 30, 2026 08:00AM
Sep 30, 2026 08:00AM
Sep 8, 2026 08:00AM Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
Aug 13, 2026 08:00AM
Aug 13, 2026 08:00AM
Aug 11, 2026 05:21PM
Jul 13, 2026 04:06PM
Jul 13, 2026 04:05PM
Jul 7, 2026 08:02AM
Jul 7, 2026 08:00AM Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization
Jun 19, 2026 04:02PM
May 28, 2026 08:00AM
May 12, 2026 05:00PM
May 6, 2026 07:00AM
May 6, 2026 07:00AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)
May 1, 2026 05:05PM
May 1, 2026 05:05PM
Apr 22, 2026 07:00AM
Apr 21, 2026 07:00AM
Apr 21, 2026 07:00AM
Apr 13, 2026 08:00AM
Mar 17, 2026 07:00AM Eupraxia reports positive symptom data from EoE trial
Mar 17, 2026 07:00AM
Mar 12, 2026 09:03PM
Jan 8, 2026 07:34AM
Jan 8, 2026 07:34AM
Nov 13, 2025 05:00PM
Nov 13, 2025 05:00PM
Nov 4, 2025 04:39PM Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results
Sep 29, 2025 05:00PM
Sep 29, 2025 05:00PM
Sep 2, 2025 08:02AM
Sep 2, 2025 08:00AM
Sep 2, 2025 08:00AM
Aug 12, 2025 04:25PM
Jul 22, 2025 05:17PM Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
Jul 8, 2025 07:00AM
Jul 8, 2025 07:00AM
Jun 2, 2025 06:30PM
May 7, 2025 02:00PM
May 6, 2025 06:00PM
May 5, 2025 07:00AM
Apr 24, 2025 05:00PM Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May
Mar 20, 2025 05:32PM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All